NO NAME
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 8gQNy6fgc3L |
|---|---|
| InChI | InChI=1S/C20H28N2S2/c1-15(21(3)4)17-11-7-9-13-19(17)23-24-20-14-10-8-12-18(20)16(2)22(5)6/h7-16H,1-6H3/t15-,16-/m1/s1 |
| InChIKey | YTDKZRKMIFRDGR-HZPDHXFCSA-N |
| Mol Weight | 360.58 g/mol |
| Molecular Formula | C20H28N2S2 |
| Exact Mass | 360.169391 g/mol |
| Enantiomer InChIKey | YTDKZRKMIFRDGR-HOTGVXAUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-biphenylyl disulfide
(E)-3-[2-[(1S)-1-(dimethylamino)ethyl]phenyl]-2-propenoic acid methyl ester
Isoquinoline, 1,2,3,4-tetrahydro-1,2-dimethyl-
1-(2-Bromophenyl)-N,N-dimethyl-3-phenyl-2-propyn-1-amine
alpha-(o-hydroxyphenyl)-4-thiomorpholineacetonitrile
2,3,9,10,16,17,23,24-Octathiapentacyclo[23.3.1.1(4,8).1(11,15).1(18,22)]dotriaconta-1(29),4,6,8(32),11,13,15(31),18,20,22(30),25,27-dodecaene, 5,7,12,14,19,21,26,28,29,30,31,32-dodecamethyl-
3-(3-Chlorophenyl)-1-(2-(methylthio)phenyl)prop-2-yn-1-ol
6,10-Bis(2-hydroxyethyl)-7,8,9,11,17,18-hexahydro-dibenzo-[e,n][1,4,8,12]-dithiadiaza-cyclopentadecine
3-METHYL-3,4-DIHYDRO-1,3-BENZOTHIAZIN-2-THIONE
3-(4-(tert-Butyl)phenyl)-1-(2-(methylthio)phenyl)prop-2-yn-1-ol
| Title | Journal or Book | Year |
|---|---|---|
| Novel Approach to the Synthesis of Enantioenriched Sulfoxides. Highly Diastereoselective Alkylation of Sulfenate Anions with 1,4-Asymmetric Induction | Organic Letters | 2002 |
Wiley Registry of Mass Spectral Data 12th Edition
Author: Wiley
The foundation library for any analytical laboratory running mass spectrometry, the Wiley Registry provides the broadest coverage available in any mass spectral library. Learn more.
KnowItAll Mass Spectral Library
Author: Wiley
The KnowItAll Mass Spectral Library offers a comprehensive collection of mass spectra, including the renowned Wiley Registry, and access to a wide range of compounds including pure organics, drugs, steroids, additives, geochemicals, petrochemicals, biomarkers, and more. Learn more.